BD Synapsys™ – Insufficient Session Expiration

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

BD Pyxis™ Products – Default Credentials

Specific BD Pyxis™ products were installed with default credentials and may presently still operate with these credentials. There may be scenarios where BD Pyxis™ products are installed with the same default local operating system credentials or domain-joined server(s) credentials that may be shared across product types. If exploited, threat actors may be able to gain privileged access to the underlying file system and could potentially exploit or gain access to ePHI or other sensitive information.

BD Pyxis Products - Hardcoded Credentials

Hardcoded credentials are used in specific BD Pyxis products. If exploited, threat actors may be able to gain access to the underlying file system and could potentially exploit application files for information that could be used to decrypt application credentials or gain access to electronic protected health information (ePHI) or other sensitive information.

BD Viper LT System - Hardcoded Credentials

BD Viper LT system, versions 2.0 and later, contains hardcoded credentials. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII). BD Viper LT system versions 4.0 and later utilize Microsoft Windows 10 and have additional Operating System hardening configurations which increase the attack complexity required to exploit this vulnerability.

BD Alaris PC Unit, Model 8015, Versions 9.33.1 and earlier and BD Alaris Systems Manager, Versions 4.33 and earlier The affected products are vulnerable to a network session authentication vulnerability within the authentication process between specified versions of the BD Alaris PC Unit and the BD Alaris Systems Manager. If exploited, an attacker could perform a denial-of-service attack on the BD Alaris PC Unit by modifying the configuration headers of data in transit. A denial-of-service attack could lead to a drop in the wireless capability of the BD Alaris PC Unit, resulting in manual operation of the PC Unit.

In BD Pyxis MedStation ES System v1.6.1 and Pyxis Anesthesia (PAS) ES System v1.6.1, a restricted desktop environment escape vulnerability exists in the kiosk mode functionality of affected devices. Specially crafted inputs could allow the user to escape the restricted environment, resulting in access to sensitive data.

BD FACSLyric Research Use Only, Windows 10 Professional Operating System, U.S. and Malaysian Releases, between November 2017 and November 2018 and BD FACSLyric IVD Windows 10 Professional Operating System US release does not properly enforce user access control to privileged accounts, which may allow for unauthorized access to administrative level functions.

In Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12, a vulnerability has been identified where existing access privileges are not restricted in coordination with the expiration of access based on active directory user account changes when the device is joined to an AD domain.

BD Alaris Gateway versions, 1.0.13,1.1.3 Build 10,1.1.3 MR Build 11,1.1.5, and 1.1.6, The web browser user interface on the Alaris Gateway Workstation does not prevent an attacker with knowledge of the IP address of the Alaris Gateway Workstation terminal to gain access to the status and configuration information of the device.

BD Alaris Gateway Workstation Versions, 1.1.3 Build 10, 1.1.3 MR Build 11, 1.2 Build 15, 1.3.0 Build 14, 1.3.1 Build 13, This does not impact the latest firmware Versions 1.3.2 and 1.6.1, Additionally, the following products using software Version 2.3.6 and below, Alaris GS, Alaris GH, Alaris CC, Alaris TIVA, The application does not restrict the upload of malicious files during a firmware update.

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

A vulnerability in ReadA version 1.1.0.2 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to issue SQL commands, which may result in loss or corruption of data.

A vulnerability in DB Manager version 3.0.1.0 and previous and PerformA version 3.0.0.0 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to issue SQL commands, which may result in data corruption.